Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1924506 | 0.95 | TSHR (0.53) | TSHRALDH1A1CYP19A1TDP1ACHE | |
| SCHEMBL21932806 | 0.93 | TSHR (0.51) | TSHRALDH1A1CYP19A1TDP1DNM1 | |
| SCHEMBL4621788 | 0.93 | TSHR (0.51) | TSHRALDH1A1CYP19A1TDP1DNM1 | |
| SCHEMBL15519654 | 0.93 | TSHR (0.51) | TSHRALDH1A1CYP19A1TDP1DNM1 | |
| SCHEMBL4578805 | 0.93 | TSHR (0.51) | TSHRALDH1A1CYP19A1TDP1DNM1 | |
| SCHEMBL5580248 | 0.93 | TSHR (0.51) | TSHRALDH1A1CYP19A1TDP1DNM1 | |
| SCHEMBL15520522 | 0.93 | TSHR (0.51) | TSHRALDH1A1CYP19A1TDP1DNM1 | |
| Isopentyl 2-Cyanoacrylate SCHEMBL450802 | 0.89 | TSHR (0.58) | TSHRALDH1A1CYP19A1TDP1ACHE | |
| SCHEMBL20943619 | 0.87 | TSHR (0.49) | TSHRALDH1A1CYP19A1BLM | |
| SCHEMBL4580407 | 0.83 | TSHR (0.63) | TSHRALDH1A1TDP1DNM1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 311 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104704-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | FUNDACIÓ INSTITUT DE INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL (ES) | 2026-05-21 | — | — | WO | claimed |
| EP-4744687-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | Aesculap AG (DE) | 2026-05-20 | — | — | EP | claimed |
| US-20250195443-A1 | Polymer Nanoaggregate Pharmaceutical Composition and Use Thereof | ANP TECHNOLOGIES, INC. (US) | 2025-06-19 | — | — | US | claimed |
| US-20250108106-A1 | NANOENCAPSULATED PHARMACEUTICAL COMPOSITION AND USE THEREOF | FULGENT GENETICS, INC. | 2025-04-03 | — | — | US | claimed |
| EP-4493219-A1 | POLYMER NANOAGGREGATE PHARMACEUTICAL COMPOSITION AND USE THEREOF | ANP Technologies, Inc. (US) | 2025-01-22 | — | — | EP | claimed |
| CN-119233828-A | Nano encapsulated pharmaceutical composition and use thereof | 福君基因公司 | 2024-12-31 | — | — | CN | claimed |
| CN-119212725-A | Polymer nano aggregate pharmaceutical composition and application thereof | ANP科技公司 | 2024-12-27 | — | — | CN | claimed |
| US-20240151732-A1 | EX VIVO METHOD FOR ANALYSING A TISSUE SAMPLE USING PROTEOMIC PROFILE MATCHING, AND ITS USE FOR THE DIAGNOSIS, PROGNOSIS OF PATHOLOGIES AND FOR PREDICTING RESPONSE TO TREATMENTS | UNIVERSITÉ DE BORDEAUX (FR) | 2024-05-09 | — | — | US | claimed |
| EP-4305424-A1 | EX VIVO METHOD FOR ANALYSING A TISSUE SAMPLE USING PROTEOMIC PROFILE MATCHING, AND ITS USE FOR THE DIAGNOSIS, PROGNOSIS OF PATHOLOGIES AND FOR PREDICTING RESPONSE TO TREATMENTS | UNIVERSITE DE BORDEAUX (FR) | 2024-01-17 | — | — | EP | claimed |
| CN-117304818-A | High-stability instant adhesive and preparation method thereof | 东莞市国象胶粘制品有限公司 | 2023-12-29 | — | — | CN | claimed |
| US-8092819-B2 | Implantable medical device coated with a bioactive agent | Cook Medical Technologies LLC. (US) | 2012-01-10 | — | — | US | claimed |
| EP-1993626-A2 | IMPLANTABLE MEDICAL DEVICE COATED WITH BIOACTIVE AGENT | Med Institute, Inc. (US) | 2008-11-26 | — | — | EP | claimed |
| US-20070207184-A1 | Implantable medical device coated with a bioactive agent | MED INSTITUTE, INC (US) | 2007-09-06 | — | — | US | claimed |
| WO-2007089592-A2 | IMPLANTABLE MEDICAL DEVICE COATED WITH BIOACTIVE AGENT | MED INSTITUTE, INC. (US) | 2007-08-09 | — | — | WO | claimed |
| US-20040028635-A1 | Block-structure copolymer consisting of a saccharide segment bound to at least a biodegradable hydrophobic segment, and corresponding particles | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) (FR) | 2004-02-12 | — | — | US | claimed |
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | claimed |
| EP-0824316-A4 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 2001-01-17 | — | — | EP | claimed |
| US-5767152-A | USING A CYANOCARBOXYLIC ACID | S.N. BIOTECH, INC. | 1998-06-16 | — | — | US | claimed |
| EP-0824316-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | Nielsen, Thor, B. (US) | 1998-02-25 | — | — | EP | claimed |
| WO-1996034526-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 1996-11-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | AREG, NGF, HDGF | TSHR 148/4885ALDH1A1 3677/4885CYP19A1 87/4885 |
| US-20250195443-A1 | Polymer Nanoaggregate Pharmaceutical Composition and Use Thereof | BRCA1, TP53, PRNP | TSHR 4578/4885ALDH1A1 4392/4885CYP19A1 3563/4885 |
| US-20250108106-A1 | NANOENCAPSULATED PHARMACEUTICAL COMPOSITION AND USE THEREOF | STING1, CGAS, MAVS | TSHR 4103/4885ALDH1A1 4767/4885CYP19A1 4076/4885 |
| US-20040028635-A1 | Block-structure copolymer consisting of a saccharide segment bound to at least a biodegradable hydrophobic segment, and corresponding particles | MSR1, CBR1, GRHPR | TSHR 972/4885ALDH1A1 956/4885CYP19A1 616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.